The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Transport of drugs from blood vessels to tumour tissue
Open accessAbstract
The effectiveness of anticancer drugs in treating a solid tumour is dependent on delivery of the drug to virtually all cancer cells in the tumour. The distribution of drug in tumour tissue depends on the plasma pharmacokinetics, the structure and function of the tumour vasculature and the transport properties of the drug as it moves through microvessel walls and in the extravascular tissue. The aim of this Review is to provide a broad, balanced perspective on the current understanding of drug transport to tumour cells and on the progress in developing methods to enhance drug delivery. First, the fundamental processes of solute transport in blood and tissue by convection and diffusion are reviewed, including the dependence of penetration distance from vessels into tissue on solute binding or uptake in tissue. The effects of the abnormal characteristics of tumour vasculature and extravascular tissue on these transport properties are then discussed. Finally, methods for overcoming limitations in drug transport and thereby achieving improved therapeutic results are surveyed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypoxia occurs in the majority of solid tumors due to a poor vascular oxygen supply that is not sufficient to meet the needs of rapidly proliferating cancer cells.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvořàk, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,969
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,925
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M., Pastan, I., & Willingham, M. (1987) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.84.21.7735 · Cited by 2,823
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 749
Song, J., Lee, Y., Kim, M.-S., Ha, G., Jang, W., Batjargal, U., Kim, Y. G., Kim, H., & Lee, J. (2025) · Lab on a Chip · doi:10.1039/d4lc00950a · Cited by 3
Bottiglieri, A., & Prakash, P. (2025) · Physics in Medicine and Biology · doi:10.1088/1361-6560/adfeb2 · Cited by 2
Manipulating anthracyclines for deeper tissue penetration and implications for glycolytic tissues
Abels, E. R., ter Linden, E., Rohling, J. H. T., Voortman, L. M., Wander, D. P. A., Janssen, L., Hornsveld, M., Overkleeft, H. S., van der Zanden, S. Y., Broekman, M. L. D., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2510263122 · Cited by 2
Directional Particle Delivery Using Freestanding BTO/LSMO Magnetoelectric Scrolls
Cao, Q. T., Zhan, N., Sun, N., Zhou, Z., Geng, Q., Zhao, H., Hao, J., Geng, H., Fang, N., & Zhou, Z. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c13910 · Cited by 2
Kaviani, M., Tayebi-Khorrami, V., Marami, Y., & Hassanian, S. M. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102861 · Cited by 3
Yisa, B. M., Aselebe, L. O., Adeosun, A. T., Ali, M. J., & Ibitoye, M. O. (2026) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-025-15214-4 · Cited by 2
Combination of vascular surgery with novel vascular targeting agents as cancer therapeutics
Dong, J., Sun, M., Cao, K., & Fang, T. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2025.1723016 · Cited by 2
Targeting T-Cells for Cancer Treatment: Current Clinical Strategies and Challenges
Rotte, A., Sopjani, M., & Bhandaru, M. (2026) · Biomedicines · doi:10.3390/biomedicines14030654 · Cited by 2
Nanoparticles reach metastatic tumours via enhanced permeability of adjacent vessels
Wang, Q., Zeng, C., Chen, Z., Hu, L., Dou, J., Ye, C., Zhu, L., Liang, Q., Pan, H., Jiang, W., et al. (2026) · Nature Nanotechnology · doi:10.1038/s41565-026-02171-8 · Cited by 2
Heterogeneous Tumour Modeling Using PhysiCell and Its Implications in Precision Medicine
Savić, M., Kurbalija, V., Balaž, I., & Ivanović, M. D. (2022) · Emergence, complexity and computation · doi:10.1007/978-3-031-04379-6_7 · Cited by 2
Novel insights into DNA methylation-based epigenetic regulation of breast tumor angiogenesis
Bhat, S. M., Prasad, P. R., & Joshi, M. B. (2023) · International review of cytology · doi:10.1016/bs.ircmb.2023.04.002 · Cited by 2
Zhdanov, V. P. (2023) · Biosystems · doi:10.1016/j.biosystems.2023.105098 · Cited by 2
Singh, S. S., Calvo, R., Kumari, A., Sable, R. V., Fang, Y., Tao, D., Hu, X., Castle, S. G., Nahar, S., Li, D., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0790 · Cited by 2
NIR-II light-driven transformable nanomedicine for precise deep-tissue photothermal therapy
Zhou, Y., Shi, T., Li, C., Liu, Y., Zou, Z., Kong, B. H., Li, X., Hou, H., Liu, X., & Li, J. (2025) · Nano Research · doi:10.26599/nr.2025.94908074 · Cited by 2
Pharmacological considerations for next-generation protein therapeutics in cardiovascular disease
Lin, E., & Momin, N. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103696 · Cited by 3
Martinez, S. K., Brandl, A., & Leary, D. M. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s241756 · Cited by 2
Mathematical Analysis for the Effects of Medicine Supplies to a Solid Tumor
Go, J. (2021) · Symmetry · doi:10.3390/sym13111988 · Cited by 2
Yuan, H., Palmer, G. M., & Dewhirst, M. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816386-3.00074-0 · Cited by 2
Self-citationOvercoming the Translational Gap – Nanotechnology in Dermal Drug Delivery
Zoschke, C., & Schäfer‐Korting, M. (2021) · doi:10.1002/9781119769644.ch11 · Cited by 2
Challenges and Emerging Problems in Nanomedicine Mediated Gene Therapy
Bhatt, S., Faridi, N., Pathak, R., Punetha, V. D., & Punetha, M. (2023) · Wiley eBooks · doi:10.1002/9781394175635.ch13 · Cited by 2
Barbosa, A. E. D. S., Azevedo-Martins, J. M., Lopes, B. A., Giardini, I. J. M., & Halder, C. V. F. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n4-250 · Cited by 2
Antiangiogenic drugs as chemosensitizer in melanoma
Quaresmini, D., & Guida, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90190-1.00003-2 · Cited by 1
Pallasch, F. B., Freytag, V., Kriegs, M., Gatzemeier, D., Mair, T., Voß, H., Riecken, K., Dawood, M., Fehse, B., Efferth, T., et al. (2024) · Cancers · doi:10.3390/cancers16122278 · Cited by 1
Salazar, F. M. V., & Arcila, I. D. P. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315194 · Cited by 1
An overview of the relationship between melatonin and drug resistance in cancers
Fazilat, A., Roshani, S., Moghadam, F. M., & Valilo, M. (2025) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2025-0016 · Cited by 2
Sun, J., Yu, H. W., & Badehnoosh, B. (2025) · Carbohydrate Polymer Technologies and Applications · doi:10.1016/j.carpta.2025.100992 · Cited by 1
Bridging the resolution gap in alpha therapy dosimetry: a space for quantitative MRI?
Marchant, J. K., & Rosen, B. R. (2025) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ae02dd · Cited by 2
Feasibility and efficacy of electromotive intraperitoneal drug delivery: A hybrid study
Saeed, N., Salavati, H., Min, J. W. S., Cosyns, S., Remaut, K., Debbaut, C., Adriaens, M., Coene, A., & Ceelen, W. P. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118619 · Cited by 1
Mohan, A., & Bagchi, P. (2025) · Biophysical Journal · doi:10.1016/j.bpj.2025.10.004 · Cited by 1
Ai, Q. Y. H., Chan, A. B. W., Chan, A. Z., Lam, J. K. W., Leung, H. S., Yu, Z., Mo, F. K. F., Wong, L. M., Chen, W., & King, A. D. (2025) · Cancer Imaging · doi:10.1186/s40644-025-00940-7 · Cited by 1
Teeraratkul, C., Tomaiuolo, M., Stalker, T. J., & Mukherjee, D. (2025) · Physics of Fluids · doi:10.1063/5.0288568 · Cited by 1
Morhard, R., Mauda‐Havakuk, M., Delgado, J. F., Kassin, M. T., Ghafoor, A., Pastan, I. H., Hassan, R., Karanian, J. W., Pritchard, W. F., Wood, B. J., et al. (2025) · CVIR Oncology · doi:10.1007/s44343-025-00027-x · Cited by 1
Qureshi, W. A., Al-Khayri, J. M., Khattak, W. A., Majeed, M., Farid, A., Anas, M., Kalsoom, A., Hussain, T., Ihsan, A., Nisa, M., et al. (2025) · Smart nanomaterials technology · doi:10.1007/978-981-96-6091-9_7 · Cited by 1
Regulatory Challenges and Approvals
Khattak, W. A., Al-Khayri, J. M., Anas, M., Farid, A., & Majeed, M. (2025) · Smart nanomaterials technology · doi:10.1007/978-981-96-6091-9_18 · Cited by 1
Mathematical modeling and sensitivity analysis of hypoxia-activated drugs
Coclite, A., Eccher, R. M., Possenti, L., Vitullo, P., Zunino, P., & Data Science Unit, F. I. I. N. D. T. (2025) · AIMS Mathematics · doi:10.3934/math.20251130 · Cited by 1
Hirakawa, K., Nomura, R., Nishimura, Y., & Okazaki, S. (2026) · Research on Chemical Intermediates · doi:10.1007/s11164-025-05888-8 · Cited by 1
Hou, S., Sun, R., Hu, S., Zhang, Q., Sun, X., Wang, L., & Wu, J. (2026) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2026.1774978 · Cited by 1
Meng, D., Li, S.-W., Chun-xiao, L., Li, Q.-R., Zhang, Y., Zeng, X., & Zhang, X.-Z. (2026) · Nano Letters · doi:10.1021/acs.nanolett.6c01150 · Cited by 1
POPESCU, R. C., Mustăciosu, C. C., Nicoară, A. I., Mereuță, P. E., Kopatz, V., Trusca, R. D., Patrascu, S., Menlivuap, E., Sovan, C.-F., Savu, D., et al. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18050525 · Cited by 1
Ji, Y., Mourdi, N., Bao, K., Su, Y., Wu, Y., Ge, Z., Choi, H. S., & Wang, Z. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115891 · Cited by 1
Comparative study of armchair and zigzag graphene quantum dots as HIV-1 protease inhibitors
Ibrahim, A., Elhaes, H., & G.Ibrahim, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-48709-7 · Cited by 1
Vascularized tumor organoids as models for interpreting therapeutic response
Huang, S., Han, S., & Wang, K. (2026) · Vascular Pharmacology · doi:10.1016/j.vph.2026.107673 · Cited by 1
Hani, U. E., Sulaiman, M., Zafar, H., & Raza, F. (2026) · Journal of Materials Chemistry B · doi:10.1039/d6tb01950a · Cited by 1
Treatment for Locoregionally Recurrent Head and Neck Cancers
Kwon, M. (2022) · Korean Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.3342/kjorl-hns.2022.00087 · Cited by 1
Optimizing Lung Cancer Radiotherapy Treatments Using Personalized Dose-Response Curves
Deasy, J. O., Jeong, J., Thor, M., Apte, A., Jackson, A., Chen, I., Wu, A. J.-C., & Rimner, A. (2022) · Medical radiology · doi:10.1007/174_2022_307 · Cited by 1
The Chemoprevention of Hereditary Diffuse Gastric Cancer
Decourtye, L., & Guilford, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-21317-5_21 · Cited by 1
Wisdom, K. M. (2023) · ALTEX · doi:10.14573/altex.2208121s · Cited by 1
Shaw, C., Riviere-Cazaux, C., Hossain, K. Z., Burns, T. C., & Khan, M. R. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104951 · Cited by 1
Overcoming Cisplatin’s Challenges: A Promising Future in Cancer Care; A Comprehensive Review
Nazari, N. A., Sarajar, B. O., Azarshin, S. Z., Jouni, F. J., Razzaghi, Z., & Zafari, J. (2024) · International Journal of Medical Toxicology and Forensic Medicine · doi:10.32598/ijmtfm.v13i4.43478 · Cited by 1
Han, L., Yogurtcu, O. N., Messan, M. R., Valega-Mackenzie, W., Nukala, U., & Yang, H. (2024) · Mathematical Medicine and Biology A Journal of the IMA · doi:10.1093/imammb/dqae003 · Cited by 1
Recent Advances and Challenges in Targeted Drug Delivery Using Biofunctional Coatings
Bal, T., Anjrini, N., & Zeroual, M. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837675555-00041 · Cited by 1
A computational model for studying drug release by drug carrier flowing through constricted channel
Srikara, V. S., Prasad, N. K., & Dalal, A. (2025) · Physics of Fluids · doi:10.1063/5.0276831 · Cited by 1
Intratumoral Manipulation of the Immune Microenvironment of Solid Tumors
Mao, L., Xu, K., Jin, T., Yan, W., & Fang, R. H. (2025) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00063 · Cited by 1
Impact of Particle Softness on Segregation of Binary Colloidal Suspensions Flowing in a Microchannel
Oura, S., Watanabe, T., Minato, H., & Suzuki, D. (2019) · KOBUNSHI RONBUNSHU · doi:10.1295/koron.2019-0003 · Cited by 1
The Evolving Role of Nanoparticles in Bacteria Mediated Cancer Therapy
Kamble, S. C., Shaikh, F. F., & Sarkar, J. (2021) · Environmental and microbial biotechnology · doi:10.1007/978-981-15-9916-3_14 · Cited by 1
Enjalbert, R., Krüger, T., & Bernabéu, M. O. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.06.535833 · Cited by 1
Gillette, A. A., Udgata, S., Schmitz, A. E., Stoecker, J. N., Deming, D. A., & Skala, M. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.23.630148 · Cited by 1
Investigating the Effect of Tumor Microvascular Architecture on Drug Transport and Distribution
Alamer, M., & Xu, X. Y. (2018) · Proceedings of the World Congress on Electrical Engineering and Computer Systems and Science · doi:10.11159/icbes18.115
Fluorescence in Colorectal Surgery
Soares, A. S., & Chand, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-15273-4_3
Metzen, M., Brüns, M., Deppert, W., & Schumacher, U. (2020) · doi:10.21203/rs.3.rs-31564/v1
Brooks, J., Zuro, D. M., Song, J. Y., Madabushi, S. S., Sanchez, J. F., Kortylewski, M., Chen, B. T., Gupta, K., Storme, G. A., FROELICH, J. W., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.23.432514
[Ongoing Evaluation of Immune-related Response Assessment in Brain Metastases].
Sheng, S., & Hu, Y. (2021) · PubMed Central · doi:10.3779/j.issn.1009-3419.2021.101.03
Intravital Optical Imaging to Monitor Anti-Tumor Immunological Response in Preclinical Models
Palmer, G. M., Wang, Y., & Mansourati, A. (2021) · Bioanalysis · doi:10.1007/978-3-030-78338-9_4
Drug Metabolism/Transport and Pharmacokinetics
Song, I.-S. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-2458-0
Mesh-Based Microfluidic Platform For Organ-On-A-Chip
Lee, J., Jung, S., & Jeon, N. L. (2022) · IEEE International Conference on Micro Electro Mechanical Systems (MEMS) · doi:10.1109/mems51670.2022.9699593
Safarova, L., Abbyasov, B., Tsoy Tatyana, G., Li, H., & Magid, E. (2022) · Proceedings of International Conference on Artificial Life and Robotics · doi:10.5954/icarob.2022.os17-4
PET imaging of hypoxia and apoptosis
Wong, F. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822960-6.00205-2
Meng, Y., Mithani, K., Vecchio, L. M., Aubert, I., & Lipsman, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813997-4.00011-6
Bright AIE Nanoparticles for Two-Photon Imaging and Localized Compound Therapy of Cancers.pdfPreprint
Li, Y., Tang, R., Liu, X., Gong, J., Zhao, Z., Sheng, Z., Zhang, J., Li, X., Niu, G., Kwok, R. T. K., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12609977
A New Frontier in Fighting Brain Cancer: Cutting Edge Magnetic Resonance Imaging Techniques
Nguyen, P., & Cain, J. A. (2022) · Journal of Student Research · doi:10.47611/jsrhs.v10i4.1952
Evaluation of vascularization parameters of experimental tumors of different morphogenesis
Pavlova, K. G., Kurnikov, A. A., Khochenkov, D. A., Khochenkova, Y. A., Glyavina, A., Turchin, I. V., Subochev, P., & Orlova, A. (2022) · International Conference Laser Optics (ICLO) · doi:10.1109/iclo54117.2022.9840315
Cui, Z., Ma, T., Yang, W., & Shuang, W. (2022) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.39.1.6584
Go, J. (2022) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2022.107279
Coupling 1D blood circulation model and substance absorption model to study drug metabolization
Huaman, I., Zun, P., Shramko, O. A., & Svitenkov, A. I. (2022) · Procedia Computer Science · doi:10.1016/j.procs.2022.10.213
Tisza, A., Klikovits, T., Török, S., Szeitz, B., Valkó, Z., Megyesfalvi, Z., Hoda, M. A., Hegedűs, B., Bonta, M., Nischkauer, W., et al. (2023) · doi:10.22541/au.167275573.37513553/v1
Zaleskis, G., Talaikis, M., Characiejus, D., Urbonas, V., Bosas, P., Darinskas, A., ZIBUTYTE, L., SIMKUS, L., Survila, Ž., Juršėnaitė, J., et al. (2023) · Anticancer Research · doi:10.21873/anticanres.16251
Kuramarohit, S., Yaourtis, A. M., Nguyen, A., Wood, M. L., Levina, A., & Lay, P. A. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202203323
An overview on cell-based therapy: Unique perspective for cancer management
Bhosale, R. R., Chavan, D. D., & Thorat, V. M. (2023) · Asian Journal of Pharmacy and Pharmacology · doi:10.31024/ajpp.2023.9.1.1
Liposomal systems containing phytochemicals for cancer therapy
Shukla, M. K., Kumar, D., Rastogi, A., & Sahu, S. K. (2023) · AIP conference proceedings · doi:10.1063/5.0162909
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancerPreprint
Hoffmann, H., Wartenberg, M., Vorlová, S., Karl‐Schöller, F., Kallius, M., Reinhardt, O., Burkhardt, V., Gätzner, S., Scheld, D., Zernecke, A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3507287/v1
Different administration routes for nanovectors in cancer immunotherapy
Vaez, A., Amani, A. M., Salehi, M., Zarei‐Behjani, Z., Rezvani, A., Dourtaj, H., Hooshmand-Ardakani, A., & Arabpour, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18770-4.00013-5
Optimal Control for Biphasic Chemotaxis Model of Tumour Growth Under Chemotherapy
Sinha, S., & Singh, P. (2024) · Acta Applicandae Mathematicae · doi:10.1007/s10440-024-00662-1
Design Exploration of Polymers for Magnetically Activated Drugs
Jensen, J. L. (2024) · doi:10.12794/metadc2356150
Son, J., Kim, J. S., Li, X., Park, H., Yoon, E., Jeon, S.-R., Kim, J.-I., Lee, J. H., & Choi, C. H. (2024) · Physica Medica · doi:10.1016/j.ejmp.2024.104825
Saghafi, F., Shaker-Ardakani, F., Meybodi, M. N., Vahedian-Ardakani, H.-A., & Sahebnasagh, A. (2025) · Recent Advances in Inflammation & Allergy Drug Discovery · doi:10.2174/0127722708312485250115052258
Fan, N., Bull, J. A., & Byrne, H. M. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012967
Jacquot, P., Muñoz-García, J., Léger, A., Babuty, A., Taupin, M., Fradet, L., Dupont, F., Heymann, M., Cinier, M., & Heymann, D. (2025) · Biomolecules · doi:10.3390/biom15040471
Zhao, X., Zhang, X., Lei, F., Guo, W., Yu, H., & Wang, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321296
Chen, E. P. (2025) · Wiley eBooks · doi:10.1002/9781119650263.ch10
Li, C., & Fan, Y.-D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6875-5_12
Advanced Drug Delivery Against Colorectal Cancer by Biopolymeric Nanoparticle Formulations
Mukherjee, S., & Karati, D. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00487-w
Wang, Y., Zhang, A., Cao, L., Lou, Z., Si, X., Zhang, X., Wang, W., & Zhu, J. N. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126230
Gilmore, A. L., Vu, H. M., Hylen, K. M., Adams, J., Epperson, R. T., Kawaguchi, B., Garrett, C. M., Ashton, N. N., Cozzone, E., Florek, C. A., et al. (2025) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.35669
Antibody-Functionalized Nanoparticles for Targeted Drug Delivery in Cancer Therapy
Marques, A. C., Costa, P. C., Velho, S., & Amaral, M. H. (2025) · Springer eBooks · doi:10.1007/978-3-032-00773-5_297 · Cited by 1
Image-guided anticancer drug delivery
Kang, H., Bao, K., Yamashita, A., Kashiwagi, S., & Choi, H. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22253-5.00021-2
Huang, G., Lin, R., Wang, H., Chen, Z., Chen, L., Bai, S., & Wang, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148993
Majumder, S., Khan, M. H. R., Chua, C. Y. X., Taraballi, F., & Righetti, R. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf354
Qi, L., Yao, X., You, X., Ding, Y., Qian, S., & Liu, G.-Y. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01923-9
Yuan, M., Chen, T., Jin, L., Zhang, P., Xie, L., Zhou, S., Fan, L., Wang, L., Zhang, C., Tang, N., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24454968
Metadata
- Authors
- Dewhirst, M. W., & Secomb, T. W.
- Affiliations
- Duke Medical Center (US)
- University of Arizona (US)
- Corresponding author
- Dewhirst, Mark W.
- Venue
- Nature Reviews Cancer
- Published
- 2017-12
- Volume
- 17
- Issue
- 12
- Pages
- 738-750
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC6371795
- OpenAlex
- W2767780867
- Cited by
- 749
- References
- 188
- Citations by year
- 2026: 63 · 2025: 98 · 2024: 91 · 2023: 87 · 2022: 108 · 2021: 97 · 2020: 104 · 2019: 62 · 2018: 38 · 2017: 1
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL034555)
- National Cancer Institute (R01CA040355)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- tumor vasculature, drug transport, solute transport, convection and diffusion, penetration depth, plasma pharmacokinetics, tumor microenvironment, tissue absorption
- MeSH terms
- Antineoplastic Agents, Biological Transport, Blood Vessels, Humans, Neoplasms, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review